Mechanism of acupuncture intervention on qi stagnation constitution based on whole transcriptome sequencing

注册号:

Registration number:

ITMCTR2000004054

最近更新日期:

Date of Last Refreshed on:

2020-10-10

注册时间:

Date of Registration:

2020-10-10

注册号状态:

Registration Status:

预注册

Prospective registration

注册题目:

基于全转录组测序的针刺干预气郁质的机制研究

Public title:

Mechanism of acupuncture intervention on qi stagnation constitution based on whole transcriptome sequencing

注册题目简写:

English Acronym:

研究课题的正式科学名称:

基于全转录组测序的针刺干预气郁质的机制研究

Scientific title:

Mechanism of acupuncture intervention on qi stagnation constitution based on whole transcriptome sequencing

研究课题的正式科学名称简写:

Scientific title acronym:

研究课题代号(代码):

Study subject ID:

在二级注册机构或其它机构的注册号:

The registration number of the Partner Registry or other register:

ChiCTR2000038946 ; ChiMCTR2000004054

申请注册联系人:

张昕

研究负责人:

谭奇纹

Applicant:

Xin Zhang

Study leader:

Qi-Wen Tan

申请注册联系人电话:

Applicant telephone:

+86 13953172234

研究负责人电话:

Study leader's telephone:

+86 13793188118

申请注册联系人传真 :

Applicant Fax:

研究负责人传真:

Study leader's fax:

申请注册联系人电子邮件:

Applicant E-mail:

doctorzhangxin@163.com

研究负责人电子邮件:

Study leader's E-mail:

doctorzhangxin@163.com

申请单位网址(自愿提供):

Study leader's website(voluntary supply):

研究负责人网址(自愿提供):

Study leader's website
(voluntary supply):

申请注册联系人通讯地址:

山东省济南市历下区经十路16369号

研究负责人通讯地址:

山东省济南市历下区经十路16369号

Applicant address:

16369 Jingshi Road, Lixia District, Ji'nan, Shandong, China

Study leader's address:

16369 Jingshi Road, Lixia District, Ji'nan, Shandong, China

申请注册联系人邮政编码:

Applicant postcode:

研究负责人邮政编码:

Study leader's postcode:

申请人所在单位:

山东中医药大学

Applicant's institution:

Shandong University of Traditional Chinese Medicine

是否获伦理委员会批准:

Approved by ethic committee:

伦理委员会批件文号:

Approved No. of ethic committee:

(2020)伦审第(023)号--KY

伦理委员会批件附件:

Approved file of Ethical Committee:

View

批准本研究的伦理委员会名称:

山东中医药大学附属医院伦理委员会

Name of the ethic committee:

Ethics Committee of Attached Hospital of Shandong University of TCM

伦理委员会批准日期:

Date of approved by ethic committee:

2020/9/8 0:00:00

伦理委员会联系人:

张鑫

Contact Name of the ethic committee:

Xin Zhang

伦理委员会联系地址:

山东省济南市历下区经十路16369号

Contact Address of the ethic committee:

16369 Jingshi Road, Lixia District, Ji'nan, Shandong, China

伦理委员会联系人电话:

Contact phone of the ethic committee:

伦理委员会联系人邮箱:

Contact email of the ethic committee:

研究实施负责(组长)单位:

山东中医药大学附属医院治未病中心

Primary sponsor:

Affiliated Hospital of Shandong University of Traditional Chinese Medicine

研究实施负责(组长)单位地址:

山东省济南市历下区经十路16369号

Primary sponsor's address:

16369 Jingshi Road, Lixia District, Ji'nan, Shandong, China

试验主办单位(项目批准或申办者):

Secondary sponsor:

国家:

中国

省(直辖市):

山东

市(区县):

济南

Country:

China

Province:

Shandong

City:

Ji'nan

单位(医院):

山东中医药大学附属医院

具体地址:

历下区经十路16369号

Institution
hospital:

Affiliated Hospital of Shandong University of Traditional Chinese Medicine

Address:

16369 Jingshi Road, Lixia District

经费或物资来源:

山东中医药大学治未病科研创新团队

Source(s) of funding:

The scientific research and innovation team of ZhiWeiBing of Shandong University of Traditional Chinese Medicine

研究疾病:

中医体质

研究疾病代码:

Target disease:

constitution of Traditional Chinese Medicine

Target disease code:

研究类型:

Study type:

干预性研究

Interventional study

研究设计:

Study design:

析因分组(即根据危险因素或暴露因素分组)

Factorial

研究所处阶段:

Study phase:

探索性研究/预试验

Pilot clinical trial

研究目的:

对气郁体质人群进行全转录组研究,通过与平和体质人群相比,筛选差异表达基因,以构建气郁体质特异的差异基因表达谱。采用针刺干预气郁质,并对干预后气郁体质人群进行全转录组测序分析,比较分析干预前后基因表达差异特征。

Objectives of Study:

The differential gene expression profile of qi stangnation constitution was constructed by screening the differentially expressed genes compared with the normal group. Acupuncture was used to intervene qi stagnation constitution, and the whole transcriptome sequencing analysis was carried out on the population with qi stagnation constitution after the intervention.

药物成份或治疗方案详述:

Description for medicine or protocol of treatment in detail:

纳入标准:

(1)年龄为18~60周岁,男女不限; (2)符合中医体质学中平和质和气郁质(《中医体质分类与判定》2009年)及西医抑郁、阈下抑郁(《精神障碍诊断与统计手册》第5版)诊断标准; (3)SDS(抑郁自评量表)≥50分和/或17项汉密尔顿抑郁量表>7分; (4)签署知情同意书。

Inclusion criteria

(1) The age is 18-60 years old, both male and female; (2) It met the diagnostic criteria of peaceful constitution and qi stagnation constitution; (3) SDS (self rating Depression Scale) >= 50 points and / or 17 items Hamilton Depression Scale > 7 points; (4) Sign informed consent.

排除标准:

(1)其他体质类型者; (2)服用与疾病相关药物,或接受其他治疗期间者; (3)患有严重心、脑、肝、肾、造血系统等疾病者; (4)沟通有障碍者或不配合研究者; (5)妊娠期、哺乳期女性及过敏体质或对针刺不耐受者。

Exclusion criteria:

(1) Other constitution types; (2) Taking disease-related drugs or receiving other treatment period; (3) Patients with serious heart, brain, liver, kidney, hematopoietic system and other diseases; (4) Communication barriers or not cooperating with researchers; (5) Women in pregnancy and lactation and those with allergic constitution or intolerance to acupuncture.

研究实施时间:

Study execute time:

From 2020-09-08

To      2021-09-08

征募观察对象时间:

Recruiting time:

From 2020-10-10

To      2021-09-08

干预措施:

Interventions:

组别:

平和质组

样本量:

30

Group:

group2

Sample size:

干预措施:

干预措施代码:

Intervention:

N/A

Intervention code:

组别:

气郁质组

样本量:

30

Group:

group of qi stagnation constitution

Sample size:

干预措施:

针刺

干预措施代码:

Intervention:

acupuncture

Intervention code:

样本总量 Total sample size : 60

研究实施地点:

Countries of recruitment
and research settings:

国家:

中国

省(直辖市):

山东

市(区县):

Country:

China

Province:

Shandong

City:

单位(医院):

山东中医药大学附属医院

单位级别:

省级三甲

Institution/hospital:

Attached Hospital of Shandong University of TCM

Level of the institution:

Tertiary A

测量指标:

Outcomes:

指标中文名:

抑郁自评量表

指标类型:

次要指标

Outcome:

SDS

Type:

Secondary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

汉密尔顿抑郁量表

指标类型:

次要指标

Outcome:

HAMD

Type:

Secondary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

肠道菌群检测

指标类型:

主要指标

Outcome:

Detection of intestinal flora

Type:

Primary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

转录组测序

指标类型:

主要指标

Outcome:

Transcriptome sequencing

Type:

Primary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

汉密尔顿焦虑量表

指标类型:

次要指标

Outcome:

HAMA

Type:

Secondary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

匹兹堡睡眠质量指数评分

指标类型:

次要指标

Outcome:

PSQI

Type:

Secondary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

体质积分

指标类型:

主要指标

Outcome:

Physique score

Type:

Primary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

采集人体标本:

Collecting sample(s)
from participants:

标本中文名:

血液

组织:

Sample Name:

blood

Tissue:

人体标本去向

使用后销毁

说明

Fate of sample 

Destruction after use

Note:

标本中文名:

粪便

组织:

Sample Name:

faeces

Tissue:

人体标本去向

使用后销毁

说明

Fate of sample 

Destruction after use

Note:

征募研究对象情况:

正在进行

Recruiting

年龄范围:

最小 18
Min age years
最大 60
Max age years

Recruiting status:

Participant age:

性别:

Gender:

男女均可

Both

随机方法(请说明由何人用什么方法产生随机序列):

非随机对照试验

Randomization Procedure (please state who generates the random number sequence and by what method):

Non-randomization.

盲法:

N/A

Blinding:

N/A

是否共享原始数据:

IPD sharing:

Yes

共享原始数据的方式(说明:请填入公开原始数据日期和方式,如采用网络平台,需填该网络平台名称和网址):

共享网盘

The way of sharing IPD”(include metadata and protocol, If use web-based public database, please provide the url):

Shared network disk

数据采集和管理(说明:数据采集和管理由两部分组成,一为病例记录表(Case Record Form, CRF),二为电子采集和管理系统(Electronic Data Capture, EDC),如ResMan即为一种基于互联网的EDC:

数据采集和数据核实管理由不同的专人负责。数据采集记录CRF表格,数据管理由山东中医药大学治未病科研创新团队储存。

Data collection and Management (A standard data collection and management system include a CRF and an electronic data capture:

Data collection and data verification management are handled by different individuals. The data collection records the CRF form and the data management is stored by the scientific research and innovation team of ZhiWeiBing of Shandong University of TCM.

数据管理委员会:

Data Managemen Committee:

暂未确定

Not yet

研究计划书或研究结果报告发表信息
(杂志名称、期、卷、页,时间;或网址):

Publication information of the protocol/research results report
(name of the journal, volume, issue, pages, time; or website):

ITMCTR BJ-ICP:07032215-5 Tip: IE8 is recommended Use the system with widescreen display resolution above